WE@HealthTech
Yael Gruenbaum-Cohen is a seasoned professional in the healthcare and biotechnology sectors, currently serving as a Partner and Head of aMoon Alpha at aMoon Fund since November 2022. In addition, Yael holds the position of Venture Partner and has been a member of 8400 - The Health Network and a co-founder of WE@HealthTech since January 2020. Previous experience includes the role of Chief Executive Officer at Andlit Therapeutics from September 2019 to August 2022, and a significant tenure at Medison Pharma from June 2014 to July 2022, where responsibilities included General Manager of Medison Ventures. Early career roles included various positions at the Ministry of Health Israel and research at the Weizmann Institute of Science. Yael earned a Doctor of Philosophy in Craniofacial Development and a DMD from The Hebrew University.
This person is not in the org chart
WE@HealthTech
Women comprise about 70% of the HealthTech industry work force. Out of the 30 companies listed in the Biomed Index there are only two women CEOs amongst a total of sixty CEOs and Chairmen. The share value of companies that include women on their boards are higher by an average of 44% (Goldman Sachs). FORTUNE 500 companies with a larger number of women in senior management positions have better financial results (Catalyst). It follows that proper representation of women in top managerial levels will serve not only social and gender equality goals, but also organizational, business, and economic goals and performance. In partnership with 8400 we introduce a HealthTech launchpad program to promote junior women managers to executive positions throughout the ecosystem.